How can we improve rural mental health?
John Kraus, MD, PhD
Advertisement
Articles by John Kraus, MD, PhD
Rejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.
New research explores ulotaront as an adjunctive therapy for adults with major depressive disorder.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
ADHD Found Connected to Substance Use Disorder, With Sex Prevalence Differences
2
Sleep as Connective Tissue: Quantifying Team Dynamics in Elite Sports
3
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
4
A Moral Injury Update: The PNHP Study and an Imminent Step Toward Peace in the Mideast
5
